Moxifloxacin EP Impurity A

Moxifloxacin EP Impurity A is a structurally related fluoroquinolone derivative characterized by a quinolone core substituted with a fluorinated piperazine ring and a methyl group at the C-8 position. It retains the parent drug's 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid scaffold but features an additional methoxy group at the C-5 position, distinguishing it from the parent compound. This impurity arises during synthetic processes due to premature termination of side-chain alkylation. It serves as a critical HPLC reference standard for quantifying process-related impurities in moxifloxacin bulk drug substance.